Document is current

Any future updates will be listed below

Response to comment on “CYP2C19 genotyping and mavacamten: predicting outcomes in normal, intermediate and rapid metabolisers in obstructive hypertrophic cardiomyopathy”

Crossref DOI link: https://doi.org/10.1007/s00228-026-04048-0

Published Online: 2026-05-14

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark